(Q43022540)

English

Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload

scientific article published on 13 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Atsushi Tateishi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masayuki Matsushita

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tomohiro Asai

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Zenichi Masuda

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mitsuhito Kuriyama

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kazushige Kanki

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kozo Ishino

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masaaki Kawada

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shunji Sano

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hideki Matsui

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

13 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

General thoracic and cardiovascular surgery

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

265-270

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

https://scigraph.springernature.com/pub.10.1007/s11748-009-0505-2

0 references

Sizing up the heart: development redux in disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of glycogen synthase kinase 3beta during heart failure is protective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-catenin downregulation is required for adaptive cardiac remodeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roles of cardiac transcription factors in cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/20549454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11748-009-0505-2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43022540&oldid=1977547913"